Beijing Qingke Biotechnology
A gene synthesis platform enterprise with an independent whole industry chain.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD340—510m (Dealroom.co estimates Dec 2022.)
Beijing China (HQ)
Authorizing premium user...